Intracoronary administration of levosimendan in cardiac surgery patients [Sepelvaltimoihin annetun levosimendaanin vaikutuksia sydänleikkauspotilailla].

Trial Profile

Intracoronary administration of levosimendan in cardiac surgery patients [Sepelvaltimoihin annetun levosimendaanin vaikutuksia sydänleikkauspotilailla].

Suspended
Phase of Trial: Phase IV

Latest Information Update: 05 Jul 2018

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Left ventricular dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jun 2018 Planned End Date changed from 15 Jun 2018 to 15 Sep 2018.
    • 19 Jun 2018 Planned End Date changed from 1 Dec 2014 to 15 Jun 2018.
    • 19 Jun 2018 Status changed from recruiting to suspended.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top